LEADER 03597nam 2200709Ia 450 001 9910453676603321 005 20200520144314.0 010 $a661178618X 010 $a1-281-78618-7 010 $a9786611786182 010 $a1-4356-7800-1 010 $a600-00-0636-5 010 $a1-60750-327-1 035 $a(CKB)1000000000553660 035 $a(EBL)363206 035 $a(OCoLC)299572780 035 $a(SSID)ssj0000212699 035 $a(PQKBManifestationID)11198875 035 $a(PQKBTitleCode)TC0000212699 035 $a(PQKBWorkID)10138264 035 $a(PQKB)10214626 035 $a(MiAaPQ)EBC363206 035 $a(Au-PeEL)EBL363206 035 $a(CaPaEBR)ebr10267483 035 $a(CaONFJC)MIL178618 035 $a(EXLCZ)991000000000553660 100 $a20080324d2008 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aNuclear receptors as molecular targets for cardiometabolic and central nervous system diseases$b[electronic resource] /$fedited by J.L. Junien and B. Staels 210 $aAmsterdam ;$aWashington, DC $cIOS Press$dc2008 215 $a1 online resource (128 p.) 225 1 $aSolvay Pharmaceuticals Conferences ;$vv. 8 300 $a"Contains papers from the Eight Solvay Pharmaceuticals Conference on Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases held in Nice (France) April 11-13, 2007" -- p. vi. 311 $a1-58603-857-5 320 $aIncludes bibliographical references and index. 327 $aTitle page; Preface; List of Contributors; Contents; Conference Preface and Keynote Lecture; Conference Preface; Keynote Lecture - An Introduction to the Nuclear Receptor Superfamily; Metabolic Control by LXR; Regulation of Cardiac Energetic by the Orphan Nuclear Receptors ERRalfa and gamma; FXR and Bile Acids: Critical Modulators of Metabolism; The Role of PPARs in Human Prediabetes; New Insights in the Role of the Intestine in Reverse Cholesterol Transport; NR4A Nuclear Receptors in the Vessel Wall; Cholesterol: Novel Target in the Treatment of Alzheimer's Disease? 327 $aPPARgamma-Mediated Effects in CNS DisordersMolecular Biology of Circadian Rhythms and Cardiometabolic Disease: Role of the Orphan Nuclear Receptor Rev-erbalfa; Author Index 330 $aFocuses on the mechanistic involvement of nuclear receptors in cardiological, metabolic and neurological disorders. This book also focuses on possible explanation of pathways involved in pathogenesis, on susceptibility to and prevention of metabolic and neurological disorders, and on the aspects of drug finding. 410 0$aSolvay Pharmaceuticals Conferences ;$vv. 8. 606 $aCentral nervous system$xDiseases$vCongresses 606 $aHeart$xDiseases$vCongresses 606 $aNuclear receptors (Biochemistry)$vCongresses 608 $aElectronic books. 615 0$aCentral nervous system$xDiseases 615 0$aHeart$xDiseases 615 0$aNuclear receptors (Biochemistry) 676 $a615.7 676 $a615.8/95 701 $aJunien$b Jean-Louis$0855795 701 $aStaels$b B$0855796 712 12$aSolvay Pharmaceuticals Conference on Nuclear Receptors as Molecular Targets for Cardiometabolic and Central Nervous System Diseases 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910453676603321 996 $aNuclear receptors as molecular targets for cardiometabolic and central nervous system diseases$91910628 997 $aUNINA